Grip strength comparison in immune-mediated neuropathies: Vigorimeter vs. Jamar

THP Draak; MHJ Pruppers; Sonja Nes; EK Vanhoutte; M (Mayienne) Bakkers; KC Gorson; WL van der Pol; RA Lewis; NC Notermans; E Nobile-Orazio; JM Leger; PYK Van den Bergh; G Lauria; V Bril; H Katzberg; MPT Lunn; J Pouget; AJ van der Kooi; LH van den Berg; Pieter van Doorn; DR Cornblath; AF Hahn; CG Faber; ISJ (Ingemar) Merkies

Grip strength comparison in immune-mediated neuropathies: Vigorimeter vs. Jamar

THP Draak
, MHJ Pruppers
, Sonja Nes
, EK Vanhoutte
, M (Mayienne) Bakkers
, KC Gorson
, WL van der Pol
, RA Lewis
, NC Notermans
, E Nobile-Orazio
, JM Leger
, PYK Van den Bergh
, G Lauria
, V Bril
, H Katzberg
, MPT Lunn
, J Pouget
, AJ van der Kooi
, LH van den Berg
, Pieter van Doorn

DR Cornblath, AF Hahn, CG Faber, ISJ (Ingemar) Merkies

Neurology

Research output: Contribution to journal › Article › Academic

43 Citations (Scopus)

Abstract

The Jamar dynamometer and Vigorimeter have been used to assess grip strength in immune-mediated neuropathies, but have never been compared to each other. Therefore, we performed a comparison study between these two devices in patients with immune-mediated neuropathies. Grip strength data were collected in 102 cross-sectional stable and 163 longitudinal (new diagnoses or changing condition) patients with Guillain-Barre syndrome (GBS), chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), gammopathy-related polyneuropathy (MGUSP), and multifocal motor neuropathy (MMN). Stable patients were assessed twice (validity/reliability studies). Longitudinal patients were assessed 3-5times during 1year. Responsiveness comparison between the two tools was examined using combined anchor-/distribution-based minimum clinically important difference (MCID) techniques. Patients were asked to indicate their preference for the Jamar or Vigorimeter. Both tools correlated highly with each other (=0.86, p<0.0001) and showed good intra-class correlation coefficients (Jamar [Right/Left hands]: ICC 0.997/0.96; Vigori: ICC 0.95/0.98). Meaningful changes were comparable between the two instruments, being higher in GBS compared to CIDP patients. In MGUSP/MMN poor responsiveness was seen. Significant more patients preferred the Vigorimeter. In conclusion, validity, reliability, and responsiveness aspects were comparable between the Jamar dynamometer and Vigorimeter. However, based on patients' preference, the Vigorimeter is recommended in future studies in immune-mediated neuropathies.

Original language	Undefined/Unknown
Pages (from-to)	269-276
Number of pages	8
Journal	Journal of the Peripheral Nervous System
Volume	20
Issue number	3
Publication status	Published - 2015

Research programs

EMC MM-04-44-02

Cite this

Draak, THP., Pruppers, MHJ., Nes, S., Vanhoutte, EK., Bakkers, M., Gorson, KC., van der Pol, WL., Lewis, RA., Notermans, NC., Nobile-Orazio, E., Leger, JM., Van den Bergh, PYK., Lauria, G., Bril, V., Katzberg, H., Lunn, MPT., Pouget, J., van der Kooi, AJ., van den Berg, LH., ... Merkies, ISJ. (2015). Grip strength comparison in immune-mediated neuropathies: Vigorimeter vs. Jamar. Journal of the Peripheral Nervous System, 20(3), 269-276.

@article{5acb215a19e141babdf7b2f2854280a6,

title = "Grip strength comparison in immune-mediated neuropathies: Vigorimeter vs. Jamar",

abstract = "The Jamar dynamometer and Vigorimeter have been used to assess grip strength in immune-mediated neuropathies, but have never been compared to each other. Therefore, we performed a comparison study between these two devices in patients with immune-mediated neuropathies. Grip strength data were collected in 102 cross-sectional stable and 163 longitudinal (new diagnoses or changing condition) patients with Guillain-Barre syndrome (GBS), chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), gammopathy-related polyneuropathy (MGUSP), and multifocal motor neuropathy (MMN). Stable patients were assessed twice (validity/reliability studies). Longitudinal patients were assessed 3-5times during 1year. Responsiveness comparison between the two tools was examined using combined anchor-/distribution-based minimum clinically important difference (MCID) techniques. Patients were asked to indicate their preference for the Jamar or Vigorimeter. Both tools correlated highly with each other (=0.86, p<0.0001) and showed good intra-class correlation coefficients (Jamar [Right/Left hands]: ICC 0.997/0.96; Vigori: ICC 0.95/0.98). Meaningful changes were comparable between the two instruments, being higher in GBS compared to CIDP patients. In MGUSP/MMN poor responsiveness was seen. Significant more patients preferred the Vigorimeter. In conclusion, validity, reliability, and responsiveness aspects were comparable between the Jamar dynamometer and Vigorimeter. However, based on patients' preference, the Vigorimeter is recommended in future studies in immune-mediated neuropathies.",

author = "THP Draak and MHJ Pruppers and Sonja Nes and EK Vanhoutte and Bakkers, \{M (Mayienne)\} and KC Gorson and \{van der Pol\}, WL and RA Lewis and NC Notermans and E Nobile-Orazio and JM Leger and \{Van den Bergh\}, PYK and G Lauria and V Bril and H Katzberg and MPT Lunn and J Pouget and \{van der Kooi\}, AJ and \{van den Berg\}, LH and \{van Doorn\}, Pieter and DR Cornblath and AF Hahn and CG Faber and Merkies, \{ISJ (Ingemar)\}",

year = "2015",

language = "Undefined/Unknown",

volume = "20",

pages = "269--276",

journal = "Journal of the Peripheral Nervous System",

issn = "1085-9489",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "3",

}

Draak, THP, Pruppers, MHJ, Nes, S, Vanhoutte, EK, Bakkers, M, Gorson, KC, van der Pol, WL, Lewis, RA, Notermans, NC, Nobile-Orazio, E, Leger, JM, Van den Bergh, PYK, Lauria, G, Bril, V, Katzberg, H, Lunn, MPT, Pouget, J, van der Kooi, AJ, van den Berg, LH, van Doorn, P, Cornblath, DR, Hahn, AF, Faber, CG & Merkies, ISJ 2015, 'Grip strength comparison in immune-mediated neuropathies: Vigorimeter vs. Jamar', Journal of the Peripheral Nervous System, vol. 20, no. 3, pp. 269-276.

TY - JOUR

T1 - Grip strength comparison in immune-mediated neuropathies: Vigorimeter vs. Jamar

AU - Draak, THP

AU - Pruppers, MHJ

AU - Nes, Sonja

AU - Vanhoutte, EK

AU - Bakkers, M (Mayienne)

AU - Gorson, KC

AU - van der Pol, WL

AU - Lewis, RA

AU - Notermans, NC

AU - Nobile-Orazio, E

AU - Leger, JM

AU - Van den Bergh, PYK

AU - Lauria, G

AU - Bril, V

AU - Katzberg, H

AU - Lunn, MPT

AU - Pouget, J

AU - van der Kooi, AJ

AU - van den Berg, LH

AU - van Doorn, Pieter

AU - Cornblath, DR

AU - Hahn, AF

AU - Faber, CG

AU - Merkies, ISJ (Ingemar)

PY - 2015

Y1 - 2015

N2 - The Jamar dynamometer and Vigorimeter have been used to assess grip strength in immune-mediated neuropathies, but have never been compared to each other. Therefore, we performed a comparison study between these two devices in patients with immune-mediated neuropathies. Grip strength data were collected in 102 cross-sectional stable and 163 longitudinal (new diagnoses or changing condition) patients with Guillain-Barre syndrome (GBS), chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), gammopathy-related polyneuropathy (MGUSP), and multifocal motor neuropathy (MMN). Stable patients were assessed twice (validity/reliability studies). Longitudinal patients were assessed 3-5times during 1year. Responsiveness comparison between the two tools was examined using combined anchor-/distribution-based minimum clinically important difference (MCID) techniques. Patients were asked to indicate their preference for the Jamar or Vigorimeter. Both tools correlated highly with each other (=0.86, p<0.0001) and showed good intra-class correlation coefficients (Jamar [Right/Left hands]: ICC 0.997/0.96; Vigori: ICC 0.95/0.98). Meaningful changes were comparable between the two instruments, being higher in GBS compared to CIDP patients. In MGUSP/MMN poor responsiveness was seen. Significant more patients preferred the Vigorimeter. In conclusion, validity, reliability, and responsiveness aspects were comparable between the Jamar dynamometer and Vigorimeter. However, based on patients' preference, the Vigorimeter is recommended in future studies in immune-mediated neuropathies.

AB - The Jamar dynamometer and Vigorimeter have been used to assess grip strength in immune-mediated neuropathies, but have never been compared to each other. Therefore, we performed a comparison study between these two devices in patients with immune-mediated neuropathies. Grip strength data were collected in 102 cross-sectional stable and 163 longitudinal (new diagnoses or changing condition) patients with Guillain-Barre syndrome (GBS), chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), gammopathy-related polyneuropathy (MGUSP), and multifocal motor neuropathy (MMN). Stable patients were assessed twice (validity/reliability studies). Longitudinal patients were assessed 3-5times during 1year. Responsiveness comparison between the two tools was examined using combined anchor-/distribution-based minimum clinically important difference (MCID) techniques. Patients were asked to indicate their preference for the Jamar or Vigorimeter. Both tools correlated highly with each other (=0.86, p<0.0001) and showed good intra-class correlation coefficients (Jamar [Right/Left hands]: ICC 0.997/0.96; Vigori: ICC 0.95/0.98). Meaningful changes were comparable between the two instruments, being higher in GBS compared to CIDP patients. In MGUSP/MMN poor responsiveness was seen. Significant more patients preferred the Vigorimeter. In conclusion, validity, reliability, and responsiveness aspects were comparable between the Jamar dynamometer and Vigorimeter. However, based on patients' preference, the Vigorimeter is recommended in future studies in immune-mediated neuropathies.

M3 - Article

SN - 1085-9489

VL - 20

SP - 269

EP - 276

JO - Journal of the Peripheral Nervous System

JF - Journal of the Peripheral Nervous System

IS - 3

ER -